Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-01-28

FDA Approved: BLEOMYCIN — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved Fresenius Kabi USA's original ANDA for bleomycin sulfate, making a generic version of bleomycin available. Bleomycin is an anticancer antibioti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bleomycin (bleomycin)

Snippet

ORIG AP for BLEOMYCIN (BLEOMYCIN SULFATE)